Excitatory amino acid inhibitors for traumatic brain injury

dc.contributor.authorGauden, Andrew J.en
dc.contributor.authorPitt, Veronicaen
dc.contributor.authorGruen, Russell L.en
dc.date.accessioned2026-01-01T14:41:19Z
dc.date.available2026-01-01T14:41:19Z
dc.date.issued2012en
dc.description.abstractThis is the protocol for a review and there is no abstract. The objectives are as follows: To assess the effects of EAAIs on patients with TBI.en
dc.description.sponsorshipVP: Work on this protocol was undertaken as part of the Neurotrauma Evidence Translation (NET) Program that is supported by grant funds received from the Victorian Transport Accident Commission. Veronica Pitt is financially supported by this grant to conduct work on this review and provide support to the lead author. • Neurotrauma Evidence Translation (NET) Program, Australia. The Neurotrauma Evidence Translation (NET) program is funded by the Victorian Neurotrauma Initiative (a subsidiary of the Transport Accident Commission, Victoria)en
dc.description.statusPeer-revieweden
dc.identifier.issn1465-1858en
dc.identifier.otherORCID:/0000-0001-8023-1957/work/167652353en
dc.identifier.scopus85076705814en
dc.identifier.urihttps://hdl.handle.net/1885/733800969
dc.language.isoenen
dc.rightsPublisher Copyright: © 2012 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.en
dc.sourceCochrane Database of Systematic Reviewsen
dc.titleExcitatory amino acid inhibitors for traumatic brain injuryen
dc.typeJournal articleen
dspace.entity.typePublicationen
local.contributor.affiliationGauden, Andrew J.; Royal Melbourne Hospitalen
local.contributor.affiliationPitt, Veronica; Monash Universityen
local.contributor.affiliationGruen, Russell L.; Monash Universityen
local.identifier.citationvolume2012en
local.identifier.doi10.1002/14651858.CD009661en
local.identifier.puree1bdff61-1d3b-41ff-a5c8-2685746b75bcen
local.identifier.urlhttps://www.scopus.com/pages/publications/85076705814en
local.type.statusPublisheden

Downloads